Redhill Biopharma
RDHL
46 hedge funds and large institutions have $28.1M invested in Redhill Biopharma in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
10% more funds holding
Funds holding: 42 → 46 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less capital invested
Capital invested by funds: $39.4M → $28.1M (-$11.2M)
47% less call options, than puts
Call options by funds: $57K | Put options by funds: $107K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$2.5M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$540K |
| 3 |
II
Ibex Investors
Denver,
Colorado
|
+$485K |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$430K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$265K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$6.28M |
| 2 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$740K |
| 3 |
KC
Kepos Capital
New York
|
-$656K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$200K |
| 5 |
Morgan Stanley
New York
|
-$105K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Boston Partners
Boston,
Massachusetts
| – | -$58K | -10 | Closed |
|
RDHL Hedge Fund Activity: Q1 2020 in Review
46 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2020, worth a combined $28.1M — down 29% from $39.4M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new RDHL positions and 3 closed out — a net gain of 7 holders — while 14 added to existing stakes and 5 trimmed.
The largest buyer was Migdal Insurance & Financial Holdings, adding an estimated $2.5M. The largest seller was 683 Capital Management, exiting entirely with an estimated $6.28M sold.
- 46 institutional investors held Redhill Biopharma (RDHL) as of Q1 2020, up from 42 in Q4 2019.
- Funds reported $28.1M of Redhill Biopharma stock for Q1 2020, down 29% quarter-over-quarter.
- 10 funds opened new Redhill Biopharma positions in Q1 2020 and 3 closed out, a net change of +7 holders.
- The largest Redhill Biopharma buyer in Q1 2020 was Migdal Insurance & Financial Holdings, an estimated $2.5M added.
- The largest Redhill Biopharma seller in Q1 2020 was 683 Capital Management, an estimated $6.28M sold.
Based on aggregated 13F filings for Q1 2020.